Brain-Immune Interactions: the role of cytokines in depression and substance use disorders

Brain-Immune Interactions: the role of cytokines in depression and substance use disorders

Bibliographic Details
Main Author:	Loftis Jennifer M
Format:	Article
Language:	English
Published:	BMC 2008-04-01
Series:	Annals of General Psychiatry

Similar Items

Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies
by: Jennifer M. Loftis, et al.
Published: (2010-03-01)

Characterizing major depressive disorder and substance use disorder using heatmaps and variable interactions: The utility of operant behavior and brain structure relationships.
by: Nicole L Vike, et al.
Published: (2024-01-01)

Characterizing major depressive disorder and substance use disorder using heatmaps and variable interactions: The utility of operant behavior and brain structure relationships
by: Nicole L. Vike, et al.
Published: (2024-01-01)

Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders
by: Loftis Jennifer M, et al.
Published: (2007-01-01)

Role of family in substance uses disorders
by: Naresh Nebhinani
Published: (2016-01-01)

Depression is one of the most common psychological disorders that comorbids with substance use disorders.
by: Mehdi Amiri
Published: (2009-05-01)

The role of enkephalinergic systems in substance use disorders
by: Lauren G. Rysztak, et al.
Published: (2022-08-01)

The role of the gut-brain axis in depression and anxiety disorders
by: M. Trigo
Published: (2021-04-01)

The association between heightened ADHD symptoms and cytokine and fatty acid concentrations during pregnancy
by: Hanna C. Gustafsson, et al.
Published: (2022-07-01)

Risk of suicide ideation in comorbid substance use disorder and major depression
by: Vivian N. Onaemo, et al.
Published: (2022-01-01)

Risk of suicide ideation in comorbid substance use disorder and major depression.
by: Vivian N Onaemo, et al.
Published: (2022-01-01)

Relationships between GAT1 and PTSD, Depression, and Substance Use Disorder
by: Kaitlin E. Bountress, et al.
Published: (2017-01-01)

The role of Effortful Control in Substance Use Disorders
by: E. Santens, et al.
Published: (2022-06-01)

Prevalence of substance use disorders among patients with systemic lupus erythematous and major depressive disorder
by: Kevin J. Varghese, et al.
Published: (2023-12-01)

Current Trends and Perspectives in the Immune Therapy for Substance Use Disorders
by: Octavian Vasiliu
Published: (2022-04-01)

Eating disorder recovery is associated with absence of major depressive disorder and substance use disorders at 22-year longitudinal follow-up
by: Ani C. Keshishian, et al.
Published: (2019-04-01)

CHARACTERISTICS OF NEUROPEPTIDE-CYTOKINE IMMUNITY LINKS IN PATIENTS WITH COMBINED CARDIOVASCULAR PATHOLOGY, PROCEEDING WITH ANXIETY/DEPRESSION DISORDER
by: A. V. Gertsev, et al.
Published: (2018-03-01)

The Role of Gamma Oscillations in the Pathophysiology of Substance Use Disorders
by: Jessica U. Ramlakhan, et al.
Published: (2020-12-01)

Effects of substance misuse and family history of substance use disorder on brain structure in patients with attention-deficit/hyperactivity disorder and healthy controls
by: M. Novi, et al.
Published: (2021-04-01)

The role of cytokines in degenerative spine disorders
by: Sutovsky J., et al.
Published: (2017-09-01)

Airway epithelium interactions with aeroallergens: Role of secreted cytokines and chemokines in innate immunity
by: Vivek Dipak Gandhi, et al.
Published: (2015-04-01)

Emotional Availability in Samples of Mothers at High Risk for Depression and With Substance Use Disorder
by: Alessandra Frigerio, et al.
Published: (2019-03-01)

The role of cytokines and hot flashes in perimenopausal depression
by: Karaoulanis Sokratis E, et al.
Published: (2012-04-01)

Circuit Investigation of Social Interaction and Substance Use Disorder Using Miniscopes
by: Nicholas J. Beacher, et al.
Published: (2021-10-01)

Mediating and Moderating Role of Depression, Conduct Disorder or Attention-Deficit/Hyperactivity Disorder in Developing Adolescent Substance Use Disorders: A Population-Based Study.
by: Kouichi Yoshimasu, et al.
Published: (2016-01-01)

Potassium Channels and Their Potential Roles in Substance Use Disorders
by: Michael T. McCoy, et al.
Published: (2021-01-01)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
by: Francisco Navarrete, et al.
Published: (2021-05-01)

Editorial: Investigating substance use disorders using neuroimaging-based brain connectivity
by: Liangsuo Ma, et al.
Published: (2022-08-01)

The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder
by: Ewelina Młynarska, et al.
Published: (2022-05-01)

Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients
by: Nobuyuki Kobayashi, et al.
Published: (2022-06-01)

Eosinophil cytokines: Emerging roles in immunity
by: Paige eLacy, et al.
Published: (2014-11-01)

THE ROLE OF CYTOKINES IN THE IMMUNITY DEVELOPMENT AT HELMINTHIASIS
by: E. A. Grishina
Published: (2016-12-01)

Circadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder
by: Iman Hashemzadeh, et al.
Published: (2021-10-01)

Glia in the cytokine-mediated onset of depression:Fine tuning the immune response
by: Wendy Karen Jo, et al.
Published: (2015-07-01)

The role of cytokines in the pathomechanism of cutaneous disorders
by: Arijit Coondoo
Published: (2012-01-01)

Inflammatory Compounds: Neuropeptide Substance Pand Cytokines
by: M.L. Castellani, et al.
Published: (2009-05-01)

Microbiota-ear-brain interaction is associated with generalized anxiety disorder through activation of inflammatory cytokine responses
by: Renyi Feng, et al.
Published: (2023-03-01)

The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD) The possible role of the Microbiota-Gut-Brain-Axis in the etiology of Major depressive Disorder (MDD)
by: T. Pieters, et al.
Published: (2022-06-01)

The effectiveness of electroconvulsive therapy in substance use disorder at pharmacological treatment failure major depression
by: P. Dannon
Published: (2023-03-01)

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder
by: Tu Z, et al.
Published: (2018-09-01)